Insider Transactions in Q1 2025 at Baxter International Inc (BAX)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 05
2025
|
David Brent Shafer Interim CEO and Chair |
BUY
Grant, award, or other acquisition
|
Direct |
76,289
+45.92%
|
-
|
Jan 31
2025
|
Christopher A. Toth EVP, Group Pres, Kidney Care |
SELL
Payment of exercise price or tax liability
|
Direct |
25,372
-19.43%
|
$811,904
$32.56 P/Share
|